Hematoma, Subdural
Accumulation of blood in the SUBDURAL SPACE between the DURA MATER and the arachnoidal layer of the MENINGES. This condition primarily occurs over the surface of a CEREBRAL HEMISPHERE, but may develop in the spinal canal (HEMATOMA, SUBDURAL, SPINAL). Subdural hematoma can be classified as the acute or the chronic form, with immediate or delayed symptom onset, respectively. Symptoms may include loss of consciousness, severe HEADACHE, and deteriorating mental status.
Subtype terms (4)
More specific conditions that are subtypes of Hematoma, Subdural in the MeSH hierarchy.
- Hematoma, Subdural, Acute
2 drugs approved
- Hematoma, Subdural, Chronic
19 drugs (18 approved, 1 experimental)
- Hematoma, Subdural, Intracranial
- Hematoma, Subdural, Spinal
Drugs by status
Phase 4 trials (2)
Phase 3 trials (7)
Phase 2 trials (5)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (5)
Organization Involved with Phase 3 Indications (16)
- ZonMw: The Netherlands Organisation for Health Research and Development
- NHS Lothian
- University of Edinburgh
- University of Toronto
- University of Virginia
- Chinese University of Hong Kong
- University of Calgary
- University of Amsterdam
- University of Montpellier
- University of Lyon
- University of Nice Sophia Antipolis
- University of Sherbrooke
- Centre hospitalier de Perpignan
- Aix-University of Marseille
- Hersenstichting Nederland
- University of Rennes
Organization Involved with Phase 2 Indications (6)
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (10)